CIK 0001478320
- Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 270907024
- Phone
- +1 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Conversion Director acquired 2,217,101 shares (conversion)
- 4 Open-market sale Chief Scientific Officer sold 11,100 shares at an average $28.77 ($319,329)
- 4 Open-market sale SVP and General Counsel sold 662 shares at $30.00 ($19,860)
- 4 Open-market sale Chief Financial Officer sold 20,000 shares at $29.87 ($597,400)
- 3 Insider Initial Statement of Ownership
- 4/A Open-market sale Director sold 5,000 shares at $30.00 ($150,000)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale SVP, Operations sold 60,000 shares at $29.14 ($1,748,400)
- 4/A Open-market sale Director sold 15,000 shares at an average $29.29 ($439,351)
- 4 Returned to the company Director returned 5,000 shares (to the company)
- 4 Open-market sale President sold 40,000 shares at $30.00 ($1,200,000)
- 4 Open-market sale President sold 135,000 shares at an average $28.98 ($3,912,585)
- 4 Returned to the company Director returned 15,000 shares (to the company)
- 4 Open-market sale President sold 160,000 shares at an average $29.73 ($4,757,060)
- 4 Exercise or conversion CEO and Chairman acquired 20,000 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $20.00 ($20,000)
- 4 Open-market buy Sr Vice President, Operations bought 11,200 shares at $20.00 ($224,000)
- 4 Conversion Director acquired 3,866,016 shares (conversion)
- 4 Conversion CEO and Chairman acquired 70,680 shares (conversion)
- 4 Conversion Chief Scientific Officer acquired 70,679 shares (conversion)
Page 26 of 28 · 544 filings